Marina Pasca Di Magliano, Ph.D.

Dr. Pasca di Magliano is an Associate Professor in the Division of HPB, Section of General Surgery. Dr. Pasca di Magliano holds a joint appointment in Cell and Developmental Biology. Dr. Pasca di Magliano earned her B.S. in 1996 at the University of Napoli in Italy before going on to receive her Ph.D. in 2002 at the Institute for Molecular Pathology in Vienna, Austria. Dr. Pasca di Magliano completed her postdoctoral training at the University of California Diabetes Center in San Francisco.

Pierre Coulombe, Ph.D.

Dr. Pierre A. Coulombe, a native of Montréal, Québec, Canada, serves as the G. Carl Huber Professor and Chair of the Department of Cell & Developmental Biology at the University of Michigan Medical School. He is jointly appointed in the Departments of Dermatology and is a member of the Comprehensive Cancer Center at the same institution. Dr. Coulombe recently joined U-M after spending 25 years on faculty, including 9 years as department chair, at the Johns Hopkins University.

Meridith Morgan, Ph.D.

Dr. Morgan received her Ph.D. in Genetics and Developmental Biology in 2002 from West Virginia University. She completed her post-doctoral training in Radiation Biology under the mentorship of Dr. Ted Lawrence at the University of Michigan during which she developed CHK1 inhibitors as chemoradiation sensitizers. In 2009, Dr. Morgan was appointed Assistant Professor of Radiation Oncology at the University of Michigan and continued her research efforts in the fields of the DNA damage response and experimental therapeutic radiation sensitizers. In 2014, Dr.

Mohammad Fallahi-Sichani, Ph.D.

Mohammad Fallahi-Sichani obtained his bachelor’s degree in Biotechnology from the University of Tehran in 2007. In 2012, he earned a Ph.D. in Chemical Engineering from the University of Michigan, where he was awarded a Rackham Predoctoral Fellowship and a Richard and Eleanor Towner Prize for Outstanding PhD Research. His PhD work co-mentored by Dr. Jennifer Linderman and Dr. Denise Kirschner combined multi-scale modeling approaches with wet-lab experiments to the study of mechanisms by which TNF signaling determines immunity to M. tuberculosis infection.

Evan T. Keller, DVM, PhD

Dr. Keller obtained Doctor of Veterinary Medicine (D.V.M.) and Masters of Preventive Veterinary Medicine (M.P.V.M.) degrees from the University of California, Davis and a doctorate (Ph.D.) in Developmental Biology from the University of Wisconsin, Madison. Currently, Dr. Keller is a Professor in the Departments of Urology and Pathology at the University of Michigan.